4th Quarter - Report — BOCKORNY GROUP, INC. for GENERIC PHARMACEUTICAL ASSOCIATION (2014)

Firm

BOCKORNY GROUP, INC.

Client

GENERIC PHARMACEUTICAL ASSOCIATION

Income

$50,000

Expenses

—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Issues Related to Biosimilar Regulation, Labeling, E-Labeling and Access

Lobbyist	Covered position, as disclosed
DAVID BOCKORNY	—
MARTINA L. BRADFORD	—
BLAIR C LARKINS	—
NICOLE VENABLE	—

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Drug Affordability and Access Issues Issues related to Risk Evaluation and Mitigation Strategies

Lobbyist	Covered position, as disclosed
DAVID BOCKORNY	—
MARTINA L. BRADFORD	—
BLAIR C LARKINS	—
NICOLE VENABLE	—

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Budget/Appropriations BUD

Ag-appropriations language related to labeling issues

Lobbyist	Covered position, as disclosed
BLAIR C LARKINS	—
NICOLE VENABLE	—

Contacted: Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.